Skip to Content

IPX066 195 (Rytary carbidopa 48.75 mg / levodopa 195 mg)

Generic Name: carbidopa/levodopa

Pill imprint IPX066 195 has been identified as Rytary carbidopa 48.75 mg / levodopa 195 mg.

Rytary is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Rytary carbidopa 48.75 mg / levodopa 195 mg is not a controlled substance under the Controlled Substance Act (CSA).

Rytary carbidopa 48.75 mg / levodopa 195 mg IPX066 195
Rytary carbidopa 48.75 mg / levodopa 195 mg IPX066 195 Front
Rytary carbidopa 48.75 mg / levodopa 195 mg IPX066 195 Back
Discount Card Promo
Rytary
Generic Name:
carbidopa/levodopa
Imprint:
IPX066 195
Strength:
carbidopa 48.75 mg / levodopa 195 mg
Color:
Blue & Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Impax Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide